Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/30174
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kaçar, Ömer | - |
dc.contributor.author | Hatipoğlu, İbrahim | - |
dc.contributor.author | Arda, Nazlı | - |
dc.contributor.author | Açılan, Ceyda | - |
dc.date.accessioned | 2022-12-30T06:49:20Z | - |
dc.date.available | 2022-12-30T06:49:20Z | - |
dc.date.issued | 2017-01-19 | - |
dc.identifier.citation | Kaçar, Ö. vd. (2017). ''The role of cell cycle progression for the apoptosis of cancer cells induced by palladium(II)-saccharinate complexes of terpyridine''. Bioorganic and Medicinal Chemistry, 25(6), 1770-1777. | en_US |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://doi.org/10.1016/j.bmc.2017.01.033 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0968089616313438 | - |
dc.identifier.uri | 1464-3391 | - |
dc.identifier.uri | http://hdl.handle.net/11452/30174 | - |
dc.description.abstract | Objectives: Palladium complexes are potent and less toxic molecules in comparison to other metal based agents. Here, we characterized two palladium(II) saccharinate complexes with terpyridine for their cell cycle specificity. Materials and methods: Cells were arrested at Gl, Gl/S boundary or mitosis using mimosine, double-Thymidine block, aphidicolin, nocodazole or colcemid, and evaluated based on morphology and flow cytometry. Synchronized cells were treated with the Pd(II) complexes, and viability was measured via MTT assay. Results: While treatment of arrested cells with the Pd(II) complexes resulted in no significant change in cell death in HCT-116 and MDA-MB-231 cells, HeLa cells were more sensitive in S/G1. The main form of cell death was found to be apoptosis. Conclusions: Pd(II) complexes appear to be cell-cycle non-specific, while cell line dependent differences may be observed. Cells die through apoptosis regardless of the cell cycle stage, which makes these complexes more promising as anti-cancer agents. | en_US |
dc.description.sponsorship | İstanbul Üniversitesi - 36696 | tr_TR |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Biochemistry & molecular biology | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Chemistry | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Cell cycle arrest | en_US |
dc.subject | Cell cycle specific | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Metal based anticancer agents | en_US |
dc.subject | Palladium(II) complex | en_US |
dc.subject | Cancer | en_US |
dc.subject | In-vitro | en_US |
dc.subject | Saccharinate complex | en_US |
dc.subject | Chemotherapeutic-agents | en_US |
dc.subject | Anticancer therapy | en_US |
dc.subject | Cytotoxic activity | en_US |
dc.subject | Cisplatin | en_US |
dc.subject | Ines | en_US |
dc.subject | Combination | en_US |
dc.subject | Mimosine | en_US |
dc.subject | Protein | en_US |
dc.subject.mesh | Antineoplastic agents | en_US |
dc.subject.mesh | Apoptosis | en_US |
dc.subject.mesh | Cell cycle | en_US |
dc.subject.mesh | Cell line, tumor | en_US |
dc.subject.mesh | Coordination complexes | en_US |
dc.subject.mesh | Drug screening assays, antitumor | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Microscopy, fluorescence | en_US |
dc.title | The role of cell cycle progression for the apoptosis of cancer cells induced by palladium(II)-saccharinate complexes of terpyridine | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000396798900006 | tr_TR |
dc.identifier.scopus | 2-s2.0-85011964410 | tr_TR |
dc.relation.tubitak | TÜBİTAK | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Kimya Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0002-2849-3332 | tr_TR |
dc.identifier.startpage | 1770 | tr_TR |
dc.identifier.endpage | 1777 | tr_TR |
dc.identifier.volume | 25 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Bioorganic and Medicinal Chemistry | en_US |
dc.contributor.buuauthor | Cevatemre, Buse | - |
dc.contributor.buuauthor | Ulukaya, Engin | - |
dc.contributor.buuauthor | Yılmaz, Veysel Turan | - |
dc.contributor.researcherid | AHD-2050-2022 | tr_TR |
dc.contributor.researcherid | K-5792-2018 | tr_TR |
dc.contributor.researcherid | L-7238-2018 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.identifier.pubmed | 28196706 | tr_TR |
dc.subject.wos | Biochemistry & molecular biology | en_US |
dc.subject.wos | Chemistry, medicinal | en_US |
dc.subject.wos | Chemistry, organic | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 (Biochemistry & molecular biology) | en_US |
dc.wos.quartile | Q2 | en_US |
dc.contributor.scopusid | 55693788600 | tr_TR |
dc.contributor.scopusid | 6602927353 | tr_TR |
dc.contributor.scopusid | 7006269202 | tr_TR |
dc.subject.scopus | Thymidine Kinase 1; Tumor Biomarkers; Cancer | en_US |
dc.subject.emtree | Aphidicolin | en_US |
dc.subject.emtree | Demecolcine | en_US |
dc.subject.emtree | Mimosine | en_US |
dc.subject.emtree | Nocodazole | en_US |
dc.subject.emtree | Palladium complex | en_US |
dc.subject.emtree | Pyridine | en_US |
dc.subject.emtree | Terpyridine | en_US |
dc.subject.emtree | Thymidine | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Antineoplastic agent | en_US |
dc.subject.emtree | Coordination compound | en_US |
dc.subject.emtree | Saccharinate(2,2'-6',2'-terpyridine)palladium(II) | en_US |
dc.subject.emtree | Apoptosis | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cancer cell line | en_US |
dc.subject.emtree | Cell cycle progression | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | G1 phase cell cycle checkpoint | en_US |
dc.subject.emtree | HCT 116 cell line | en_US |
dc.subject.emtree | HeLa cell line | en_US |
dc.subject.emtree | MDA-MB-231 cell line | en_US |
dc.subject.emtree | Mitosis inhibitioc | en_US |
dc.subject.emtree | Apoptosis | en_US |
dc.subject.emtree | Cell cycle | en_US |
dc.subject.emtree | Drug effects | en_US |
dc.subject.emtree | Drug screening | en_US |
dc.subject.emtree | Fluorescence microscopy | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Tumor cell line | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.